At the end of the summer, Josefine Bresmar started as Flemingsberg Science’s new Director of Communications. One of Josefine’s main tasks will be to develop the Flemingsberg Business Community network.
Sprint Bioscience has licensed its VADA cancer programme to US-based Day One Biopharmaceuticals. The deal is Sprint Bioscience’s largest to date and could be worth around SEK 3.4 billion. In the next two years, the two companies will take the steps towards clinical testing of a new cancer drug.
Bolagen fortsätter att strömma till A Working Lab (AWL) i Flemingsberg. Det som attraherar dem är främst flexibiliteten och de korta kontrakten, men också den starka forskningsinfrastrukturen i Flemingsberg.
XNK Therapeutics today announced that it has received a GMP manufacturing license and a certificate of GMP compliance from the Swedish Medical Products Agency, which means that the company can produce at scale for its planned clinical studies.
Work continues to strengthen collaboration between small and medium-sized enterprises and the research infrastructures in Flemingsberg. Flemingsberg Science leads this project together with Karolinska Institutet and the Center for Innovative Medicine (CIMED).
Two-thirds of all rubber used in the world is made from oil. But now a sustainable process is being developed by a company named Reselo, which involves extracting rubber from birch bark. The bark itself is a residual product from today’s forest industry.
Flemingsbergs Science Award STARTUP 2023 went to Scientify Research. The online service gathers research funding from the whole world in an open database. It offers a host of functions that make it easier for researchers to find relevant funding opportunities.
Now is the time for this year's Almedal week. Don't miss Fabege and Huddinge municipality's events with a focus on sustainable urban development.
Campus Flemingsberg boasts a highly robust ecosystem in the field of Life Science, characterized by world-class education, research, and entrepreneurship, with Karolinska University Hospital serving as a central hub. The foundation plays a vital role in promoting the visibility of this ecosystem, ensuring its continuous development and facilitating new establishments.
AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.